Literature DB >> 22616082

Juvenile angiofibroma: major and minor complications of preoperative embolization.

A I Ogawa1, M A Fornazieri, L V da Silva, F R Pinna, R L Voegels, L U Sennes, P P Junior, J G Caldas.   

Abstract

INTRODUCTION: Juvenile angiofibromas (JA) are highly vascular, benign tumours for which surgery is the treatment of choice. In most services, embolisation is performed prior to resection. Nevertheless, there are few data on the complications of preoperative embolisation for JA. AIM: To describe major and minor complications of preoperative embolisation in a 32-year experience of patients undergoing surgical resection of JA at a tertiary hospital.
METHODS: Retrospective chart review study of 170 patients who underwent surgical resection of JA at a tertiary hospital between September 1976 and July 2008.
RESULTS: All patients were male. Age ranged from 9 to 26 years. Ninety-one patients had no complications after embolisation. Overall, 105 complication events occurred of which four major and 101 minor.
CONCLUSION: In our series, preoperative embolisation for JA produced no irreversible complications and no aesthetic or functional sequelae. The vast majority of complications were transient and amenable to clinical management.

Entities:  

Mesh:

Year:  2012        PMID: 22616082     DOI: 10.4193/Rhino11.086

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  2 in total

1.  Comprehensive preoperative staging system for endoscopic single and multicorridor approaches to juvenile nasal angiofibromas.

Authors:  Trichy N Janakiram; Shilpee B Sharma; Ekkehard Kasper; Onkar Deshmukh; Iype Cherian
Journal:  Surg Neurol Int       Date:  2017-04-26

2.  Complications in the endoscopic and endoscopic-assisted treatment of juvenile nasopharyngeal angiofibroma with intracranial extension.

Authors:  Maria Dantas Costa Lima Godoy; Thiago Freire Pinto Bezerra; Fabio de Rezende Pinna; Richard Louis Voegels
Journal:  Braz J Otorhinolaryngol       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.